[HTML][HTML] Brazilian guidelines of hypertension–2020
…, SL Amaral, SR Ferreira-Filho, SE Kaiser… - Arquivos brasileiros de …, 2021 - SciELO Brasil
… Sergio Emanuel Kaiser Engage, Alecardio, RED-HF, Odissey-Outcomes, SELECT
Amgen, Novo Nordisk, Novartis, astrazeneca, Momenta Farma, Daiichi-Sankyo, Pfizer …
Amgen, Novo Nordisk, Novartis, astrazeneca, Momenta Farma, Daiichi-Sankyo, Pfizer …
[HTML][HTML] Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer
S Kaiser, YK Park, JL Franklin, RB Halberg, M Yu… - Genome biology, 2007 - Springer
Background The expression of carcino-embryonic antigen by colorectal cancer is an example
of oncogenic activation of embryonic gene expression. Hypothesizing that oncogenesis-…
of oncogenic activation of embryonic gene expression. Hypothesizing that oncogenesis-…
Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis
…, O Alpan, B Enav, I Hirano, K Nadeau, S Kaiser… - Journal of Allergy and …, 2015 - Elsevier
… Rothenberg MD, PhD a , Ting Wen PhD a , Allison Greenberg BA a b , Oral Alpan MD c ,
Benjamin Enav MD c d , Ikuo Hirano MD e , Kari Nadeau MD, PhD f , Sergio Kaiser PhD g , …
Benjamin Enav MD c d , Ikuo Hirano MD e , Kari Nadeau MD, PhD f , Sergio Kaiser PhD g , …
[HTML][HTML] Updated cardiovascular prevention guideline of the Brazilian Society of Cardiology-2019
…, JC Schneider, MHV Assad, SE Kaiser… - Arquivos brasileiros de …, 2019 - SciELO Brasil
Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …
Presynaptic nicotinic receptors modulating dopamine release in the rat striatum
S Wonnacott, S Kaiser, A Mogg, L Soliakov… - European journal of …, 2000 - Elsevier
The modulation of striatal dopamine release by presynaptic nicotinic acetylcholine receptors
is well documented for both synaptosomes and slices. Because the latter retain local …
is well documented for both synaptosomes and slices. Because the latter retain local …
α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H] dopamine release in rat striatal slices via glutamate release
S Kaiser, S Wonnacott - Molecular pharmacology, 2000 - ASPET
Nicotinic agonists elicit the release of dopamine from striatal synaptosomes by acting on
presynaptic nicotinic acetylcholine receptors (nAChRs) on dopamine nerve terminals. Both α3β2…
presynaptic nicotinic acetylcholine receptors (nAChRs) on dopamine nerve terminals. Both α3β2…
Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues
…, J Williams, P Ackerman, S Kong, AG Jegga, S Kaiser… - Cancer research, 2006 - AACR
Malignant peripheral nerve sheath tumors (MPNST) are highly invasive soft tissue sarcomas
that arise within the peripheral nerve and frequently metastasize. To identify molecular …
that arise within the peripheral nerve and frequently metastasize. To identify molecular …
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
…, T Mehta, A Hardiman, E Sites, S Kaiser… - EMBO molecular …, 2009 - embopress.org
Understanding the biological pathways critical for common neurofibromatosis type 1 (NF1)
peripheral nerve tumours is essential, as there is a lack of tumour biomarkers, prognostic …
peripheral nerve tumours is essential, as there is a lack of tumour biomarkers, prognostic …
UB-165: a novel nicotinic agonist with subtype selectivity implicates the α4β2* subtype in the modulation of dopamine release from rat striatal synaptosomes
CGV Sharples, S Kaiser, L Soliakov… - Journal of …, 2000 - Soc Neuroscience
Presynaptic nicotinic acetylcholine receptors (nAChRs) on striatal synaptosomes stimulate
dopamine release. Partial inhibition by the α3β2-selective α-conotoxin-MII indicates …
dopamine release. Partial inhibition by the α3β2-selective α-conotoxin-MII indicates …
[HTML][HTML] A proteogenomic view of Parkinson's disease causality and heterogeneity
S Kaiser, L Zhang, B Mollenhauer, J Jacob… - npj Parkinson's …, 2023 - nature.com
The pathogenesis and clinical heterogeneity of Parkinson’s disease (PD) have been
evaluated from molecular, pathophysiological, and clinical perspectives. High-throughput …
evaluated from molecular, pathophysiological, and clinical perspectives. High-throughput …